Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida

Authors: Sebastiaan Hermanus Johannes Zegers, Jeanne Dieleman, Tjomme van der Bruggen, Jan Kimpen, Catharine de Jong-de Vos van Steenwijk

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Bacterial resistance to antibiotics is an increasingly threatening consequence of antimicrobial exposure for many decades now. In urinary tract infections (UTIs), antibiotic prophylaxis (AP) increases bacterial resistance. We studied the resistance patterns of positive urinary cultures in spina bifida children on clean intermittent catheterization, both continuing and stopping AP.

Methods

In a cohort of 176 spina bifida patients, 88 continued and 88 stopped using AP. During 18 months, a fortnightly catheterized urine sample for bacterial pathogens was cultured. UTIs and significant bacteriuria (SBU) were defined as a positive culture with a single species of bacteria, respectively with and without clinical symptoms and leukocyturia. We compared the percentage of resistance to commonly used antibiotics in the isolated bacteria in both groups.

Results

In a total of 4917 cultures, 713 (14.5%) had a positive monoculture, 54.3% of which were Escherichia coli. In the group stopping AP, the resistance percentage to antibiotics in UTI / SBU bacteria was lower than in the group remaining on AP, even when excluding the administered prophylaxis.

Conclusion

Stopping antibiotic prophylaxis for urinary tract infections is associated with reduced bacterial resistance to antibiotics in children with spina bifida.

Trial registration

ISRCTN ISRCTN56278131. Registered 20 December 2005.
Literature
1.
go back to reference RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367–76.CrossRef RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367–76.CrossRef
2.
go back to reference Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr. 2013;163(5):1417–21.CrossRefPubMed Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr. 2013;163(5):1417–21.CrossRefPubMed
3.
go back to reference Ilic K, Jakovljevic E, Skodric-Trifunovic V. Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare. Eur J Pediatr. 2012;171(5):767–77.CrossRefPubMed Ilic K, Jakovljevic E, Skodric-Trifunovic V. Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare. Eur J Pediatr. 2012;171(5):767–77.CrossRefPubMed
4.
go back to reference Shepherd AK, Pottinger PS. Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am. 2013;97(4):737–57. xii.CrossRefPubMed Shepherd AK, Pottinger PS. Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am. 2013;97(4):737–57. xii.CrossRefPubMed
5.
go back to reference Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents. 2011;38(Suppl):42–50.CrossRefPubMed Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents. 2011;38(Suppl):42–50.CrossRefPubMed
7.
go back to reference Lapides J. Urinary diversion. Surgery. 1971;69(0039-6060; 0039-6060; 1):142–54.PubMed Lapides J. Urinary diversion. Surgery. 1971;69(0039-6060; 0039-6060; 1):142–54.PubMed
8.
go back to reference Schlager TA, Dilks S, Trudell J, Whittam TS, Hendley JO. Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr. 1995;126(0022-3476; 3):490–6.CrossRefPubMed Schlager TA, Dilks S, Trudell J, Whittam TS, Hendley JO. Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr. 1995;126(0022-3476; 3):490–6.CrossRefPubMed
9.
go back to reference Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr. 1998;132(0022-3476; 4):704–8.CrossRefPubMed Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr. 1998;132(0022-3476; 4):704–8.CrossRefPubMed
10.
go back to reference Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, De Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49(0302-2838; 5):908–13.CrossRefPubMed Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, De Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49(0302-2838; 5):908–13.CrossRefPubMed
11.
go back to reference Zegers BS, Winkler-Seinstra PL, Uiterwaal CS, de Jong TV, Kimpen JL, van de Jong-de Vos van Steenwijk CC. Urinary tract infections in children with spina bifida: an inventory of 41 European centers. Pediatr Nephrol. 2009;24(0931-041; 4):783–8.CrossRefPubMed Zegers BS, Winkler-Seinstra PL, Uiterwaal CS, de Jong TV, Kimpen JL, van de Jong-de Vos van Steenwijk CC. Urinary tract infections in children with spina bifida: an inventory of 41 European centers. Pediatr Nephrol. 2009;24(0931-041; 4):783–8.CrossRefPubMed
12.
go back to reference Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra P, Houterman S, Verpoorten C, de Jong-de Vos van Steenwijk C. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol. 2011;186(6):2365–70.CrossRefPubMed Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra P, Houterman S, Verpoorten C, de Jong-de Vos van Steenwijk C. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol. 2011;186(6):2365–70.CrossRefPubMed
13.
go back to reference Bitsori M, Maraki S, Galanakis E. Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis. Pediatr Nephrol. 2014;29(6):1053–8.CrossRefPubMed Bitsori M, Maraki S, Galanakis E. Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis. Pediatr Nephrol. 2014;29(6):1053–8.CrossRefPubMed
14.
go back to reference Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(1538-3598; 2):179–86.CrossRefPubMed Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(1538-3598; 2):179–86.CrossRefPubMed
15.
go back to reference Lutter SA, Currie ML, Mitz LB, Greenbaum LA. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med. 2005;159(10):924–8.CrossRefPubMed Lutter SA, Currie ML, Mitz LB, Greenbaum LA. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med. 2005;159(10):924–8.CrossRefPubMed
17.
go back to reference Narchi H, Al-Hamdani M. Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist. 2010;16(1931-8448; 1076-6294; 2):151–4.CrossRefPubMed Narchi H, Al-Hamdani M. Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist. 2010;16(1931-8448; 1076-6294; 2):151–4.CrossRefPubMed
18.
go back to reference Nelson CP, Hoberman A, Shaikh N, Keren R, Mathews R, Greenfield SP, Mattoo TK, Gotman N, Ivanova A, Moxey-Mims M, Carpenter MA, Chesney RW: Antimicrobial Resistance and Urinary Tract Infection Recurrence. Pediatrics 2016, 137(4):10.1542/peds.2015-2490. Epub 2016 Mar 11. Nelson CP, Hoberman A, Shaikh N, Keren R, Mathews R, Greenfield SP, Mattoo TK, Gotman N, Ivanova A, Moxey-Mims M, Carpenter MA, Chesney RW: Antimicrobial Resistance and Urinary Tract Infection Recurrence. Pediatrics 2016, 137(4):10.​1542/​peds.​2015-2490. Epub 2016 Mar 11.
19.
go back to reference Stokes HW, Gillings MR. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol Rev. 2011;35(5):790–819.CrossRefPubMed Stokes HW, Gillings MR. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol Rev. 2011;35(5):790–819.CrossRefPubMed
20.
go back to reference Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128(6):1037–50.CrossRefPubMed Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128(6):1037–50.CrossRefPubMed
21.
go back to reference Friedman S, Reif S, Assia A, Mishaal R, Levy I. Clinical and laboratory characteristics of non-E. coli urinary tract infections. Arch Dis Child. 2006;91(10):845–6.CrossRefPubMedPubMedCentral Friedman S, Reif S, Assia A, Mishaal R, Levy I. Clinical and laboratory characteristics of non-E. coli urinary tract infections. Arch Dis Child. 2006;91(10):845–6.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Wagenlehner FM, Cek M, Naber KG, Kiyota H, Bjerklund-Johansen TE. Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol. 2012;30(1):59–67.CrossRefPubMed Wagenlehner FM, Cek M, Naber KG, Kiyota H, Bjerklund-Johansen TE. Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol. 2012;30(1):59–67.CrossRefPubMed
Metadata
Title
The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida
Authors
Sebastiaan Hermanus Johannes Zegers
Jeanne Dieleman
Tjomme van der Bruggen
Jan Kimpen
Catharine de Jong-de Vos van Steenwijk
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2166-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue